Grant Instruments, a leading provider of scientific instruments, is pleased to announce a strategic investment from Royston Instruments Ltd. This partnership strengthens Grant Instruments’ position in the life sciences market, unlocking investment which will enable new opportunities for growth, innovation, and enhanced customer offerings.
With a strong legacy in delivering high-quality scientific solutions, Grant Instruments has built a reputation for excellence and reliability. This investment provides the company with additional resources to accelerate commercial expansion and product development in its facility in the United Kingdom.
"We are delighted to partner with Grant Instruments, a company with an outstanding heritage in scientific instrumentation. We see tremendous potential in this collaboration and look forward to supporting Grant Instruments as they expand their product offering, enhance their innovation pipeline, and strengthen their market position," said David Newble, Chairman of Royston Instruments Ltd. Royston Instruments' support, with funding from BroadOak Capital Partners, will enable Grant Instruments to strengthen its product portfolio and market reach. The company will continue to operate as usual, with no disruption to customers, maintaining the same trusted team, processes, and commitment to quality.
“David and Mark have put together a great plan for one of the most venerable companies in the life sciences tools industry. We are happy to provide Royston and Grant with support to realize their shared vision,” Bill Snider of BroadOak Capital Partners added.
"This acquisition and investment marks a pivotal moment in our journey. With Royston Instruments' support, we are well-positioned to scale operations, accelerate technological advancements, and continue delivering high-quality solutions to our customers. It’s an exciting time for Grant Instruments as we embark on this next phase of growth," said Mark Davison, CEO of Grant Instruments.
